Such diversity in activation can have two non-mutually exclusive explanations: clonal genetic heterogeneity of MM cells, or low-level long-term activation of p65/NF-κB due to spatially restricted autocrine/paracrine secretion of NF-κB activating molecules. This evidence concerns the gene NFKB1 and Miyoshi myopathy.